{"id":"https://openalex.org/W2020847930","doi":"https://doi.org/10.1007/s10822-007-9139-6","title":"Generation of in-silico cytochrome P450 1A2, 2C9, 2C19, 2D6, and 3A4 inhibition QSAR models","display_name":"Generation of in-silico cytochrome P450 1A2, 2C9, 2C19, 2D6, and 3A4 inhibition QSAR models","publication_year":2007,"publication_date":"2007-10-01","ids":{"openalex":"https://openalex.org/W2020847930","doi":"https://doi.org/10.1007/s10822-007-9139-6","mag":"2020847930","pmid":"https://pubmed.ncbi.nlm.nih.gov/18034311"},"language":"en","primary_location":{"id":"doi:10.1007/s10822-007-9139-6","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s10822-007-9139-6","pdf_url":null,"source":{"id":"https://openalex.org/S64621741","display_name":"Journal of Computer-Aided Molecular Design","issn_l":"0920-654X","issn":["0920-654X","1573-4951"],"is_oa":false,"is_in_doaj":false,"is_core":true,"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Computer-Aided Molecular Design","raw_type":"journal-article"},"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067710298","display_name":"M. Paul Gleeson","orcid":"https://orcid.org/0000-0001-6998-7446"},"institutions":[{"id":"https://openalex.org/I143804889","display_name":"Loughborough University","ror":"https://ror.org/04vg4w365","country_code":"GB","type":"education","lineage":["https://openalex.org/I143804889"]},{"id":"https://openalex.org/I4210099842","display_name":"GlaxoSmithKline (India)","ror":"https://ror.org/01tvt4d48","country_code":"IN","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210099842"]},{"id":"https://openalex.org/I4210116875","display_name":"AstraZeneca (Brazil)","ror":"https://ror.org/026m9xy48","country_code":"BR","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210116875"]}],"countries":["BR","GB","IN"],"is_corresponding":false,"raw_author_name":"M. Paul Gleeson","raw_affiliation_strings":["Department of Physical & Metabolic Sciences, AstraZeneca R&D Charnwood, Bakewell Road, Loughborough, Leicestershire LE11 5RH, UK. paul.x.gleeson@gsk.com","GlaxoSmithKline Medicines Research Centre","AstraZeneca R&D Charnwood"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Physical & Metabolic Sciences, AstraZeneca R&D Charnwood, Bakewell Road, Loughborough, Leicestershire LE11 5RH, UK. paul.x.gleeson@gsk.com","institution_ids":["https://openalex.org/I143804889"]},{"raw_affiliation_string":"GlaxoSmithKline Medicines Research Centre","institution_ids":["https://openalex.org/I4210099842"]},{"raw_affiliation_string":"AstraZeneca R&D Charnwood","institution_ids":["https://openalex.org/I4210116875"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025766512","display_name":"A. M. Davis","orcid":"https://orcid.org/0000-0001-7955-6236"},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]},{"id":"https://openalex.org/I143804889","display_name":"Loughborough University","ror":"https://ror.org/04vg4w365","country_code":"GB","type":"education","lineage":["https://openalex.org/I143804889"]},{"id":"https://openalex.org/I4210116875","display_name":"AstraZeneca (Brazil)","ror":"https://ror.org/026m9xy48","country_code":"BR","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210116875"]}],"countries":["BR","GB"],"is_corresponding":false,"raw_author_name":"Andrew M. Davis","raw_affiliation_strings":["Department of Physical & Metabolic Sciences, AstraZeneca R&D Charnwood, Bakewell Road, Loughborough, Leicestershire, LE11 5RH, UK","AstraZeneca R&D Charnwood"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Physical & Metabolic Sciences, AstraZeneca R&D Charnwood, Bakewell Road, Loughborough, Leicestershire, LE11 5RH, UK","institution_ids":["https://openalex.org/I143804889","https://openalex.org/I105036370"]},{"raw_affiliation_string":"AstraZeneca R&D Charnwood","institution_ids":["https://openalex.org/I4210116875"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005269003","display_name":"Kamaldeep K. Chohan","orcid":null},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]},{"id":"https://openalex.org/I143804889","display_name":"Loughborough University","ror":"https://ror.org/04vg4w365","country_code":"GB","type":"education","lineage":["https://openalex.org/I143804889"]},{"id":"https://openalex.org/I4210116875","display_name":"AstraZeneca (Brazil)","ror":"https://ror.org/026m9xy48","country_code":"BR","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210116875"]}],"countries":["BR","GB"],"is_corresponding":false,"raw_author_name":"Kamaldeep K. Chohan","raw_affiliation_strings":["Department of Physical & Metabolic Sciences, AstraZeneca R&D Charnwood, Bakewell Road, Loughborough, Leicestershire, LE11 5RH, UK","AstraZeneca R&D Charnwood"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Physical & Metabolic Sciences, AstraZeneca R&D Charnwood, Bakewell Road, Loughborough, Leicestershire, LE11 5RH, UK","institution_ids":["https://openalex.org/I143804889","https://openalex.org/I105036370"]},{"raw_affiliation_string":"AstraZeneca R&D Charnwood","institution_ids":["https://openalex.org/I4210116875"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037657912","display_name":"Stuart W. Paine","orcid":"https://orcid.org/0000-0001-9443-2311"},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]},{"id":"https://openalex.org/I143804889","display_name":"Loughborough University","ror":"https://ror.org/04vg4w365","country_code":"GB","type":"education","lineage":["https://openalex.org/I143804889"]},{"id":"https://openalex.org/I4210116875","display_name":"AstraZeneca (Brazil)","ror":"https://ror.org/026m9xy48","country_code":"BR","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210116875"]}],"countries":["BR","GB"],"is_corresponding":false,"raw_author_name":"Stuart W. Paine","raw_affiliation_strings":["Department of Physical & Metabolic Sciences, AstraZeneca R&D Charnwood, Bakewell Road, Loughborough, Leicestershire, LE11 5RH, UK","AstraZeneca R&D Charnwood"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Physical & Metabolic Sciences, AstraZeneca R&D Charnwood, Bakewell Road, Loughborough, Leicestershire, LE11 5RH, UK","institution_ids":["https://openalex.org/I143804889","https://openalex.org/I105036370"]},{"raw_affiliation_string":"AstraZeneca R&D Charnwood","institution_ids":["https://openalex.org/I4210116875"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030997667","display_name":"Scott Boyer","orcid":null},"institutions":[{"id":"https://openalex.org/I4210114036","display_name":"AstraZeneca (Singapore)","ror":"https://ror.org/023p4rz42","country_code":"SG","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210114036"]},{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE","SG"],"is_corresponding":false,"raw_author_name":"Scott Boyer","raw_affiliation_strings":["Computational Toxicology, Safety Assessment, AstraZeneca R&D, Molndal, Sweden","AstraZeneca R&D"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Computational Toxicology, Safety Assessment, AstraZeneca R&D, Molndal, Sweden","institution_ids":["https://openalex.org/I4210143795"]},{"raw_affiliation_string":"AstraZeneca R&D","institution_ids":["https://openalex.org/I4210114036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110059168","display_name":"Claire L. Gavaghan","orcid":null},"institutions":[{"id":"https://openalex.org/I4210114036","display_name":"AstraZeneca (Singapore)","ror":"https://ror.org/023p4rz42","country_code":"SG","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210114036"]},{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE","SG"],"is_corresponding":false,"raw_author_name":"Claire L. Gavaghan","raw_affiliation_strings":["Computational Toxicology, Safety Assessment, AstraZeneca R&D, Molndal, Sweden","AstraZeneca R&D"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Computational Toxicology, Safety Assessment, AstraZeneca R&D, Molndal, Sweden","institution_ids":["https://openalex.org/I4210143795"]},{"raw_affiliation_string":"AstraZeneca R&D","institution_ids":["https://openalex.org/I4210114036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002523870","display_name":"Catrin Hasselgren Arnby","orcid":null},"institutions":[{"id":"https://openalex.org/I4210114036","display_name":"AstraZeneca (Singapore)","ror":"https://ror.org/023p4rz42","country_code":"SG","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210114036"]},{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE","SG"],"is_corresponding":false,"raw_author_name":"Catrin Hasselgren Arnby","raw_affiliation_strings":["Computational Toxicology, Safety Assessment, AstraZeneca R&D, Molndal, Sweden","AstraZeneca R&D"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Computational Toxicology, Safety Assessment, AstraZeneca R&D, Molndal, Sweden","institution_ids":["https://openalex.org/I4210143795"]},{"raw_affiliation_string":"AstraZeneca R&D","institution_ids":["https://openalex.org/I4210114036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064064040","display_name":"Cecilia Kankkonen","orcid":"https://orcid.org/0000-0001-6547-1792"},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]},{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["GB","SE"],"is_corresponding":false,"raw_author_name":"Cecilia Kankkonen","raw_affiliation_strings":["HTS Screening, AstraZeneca R&D M\u00f6lndal, 431 83, Molndal, Sweden","AstraZeneca R&D Molndal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HTS Screening, AstraZeneca R&D M\u00f6lndal, 431 83, Molndal, Sweden","institution_ids":["https://openalex.org/I4210143795"]},{"raw_affiliation_string":"AstraZeneca R&D Molndal","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5028394986","display_name":"Nan H. Albertson","orcid":null},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]},{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["GB","SE"],"is_corresponding":false,"raw_author_name":"Nan Albertson","raw_affiliation_strings":["Discovery DMPK & BAC, AstraZeneca R&D M\u00f6lndal, Molndal, Sweden","AstraZeneca R&D Molndal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery DMPK & BAC, AstraZeneca R&D M\u00f6lndal, Molndal, Sweden","institution_ids":["https://openalex.org/I4210143795"]},{"raw_affiliation_string":"AstraZeneca R&D Molndal","institution_ids":["https://openalex.org/I105036370"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":9,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2890,"currency":"EUR","value_usd":3690},"apc_paid":null,"fwci":5.9862,"has_fulltext":false,"cited_by_count":64,"citation_normalized_percentile":{"value":0.96360207,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":90,"max":99},"biblio":{"volume":"21","issue":"10-11","first_page":"559","last_page":"573"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9998000264167786,"subfield":{"id":"https://openalex.org/subfields/1703","display_name":"Computational Theory and Mathematics"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9998000264167786,"subfield":{"id":"https://openalex.org/subfields/1703","display_name":"Computational Theory and Mathematics"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9973999857902527,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10908","display_name":"Analytical Chemistry and Chromatography","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/1607","display_name":"Spectroscopy"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/quantitative-structure\u2013activity-relationship","display_name":"Quantitative structure\u2013activity relationship","score":0.8769270181655884},{"id":"https://openalex.org/keywords/mean-squared-error","display_name":"Mean squared error","score":0.6086426973342896},{"id":"https://openalex.org/keywords/in-silico","display_name":"In silico","score":0.5244691371917725},{"id":"https://openalex.org/keywords/partial-least-squares-regression","display_name":"Partial least squares regression","score":0.5166683197021484},{"id":"https://openalex.org/keywords/mathematics","display_name":"Mathematics","score":0.5064398050308228},{"id":"https://openalex.org/keywords/linear-regression","display_name":"Linear regression","score":0.48308637738227844},{"id":"https://openalex.org/keywords/ranking","display_name":"Ranking (information retrieval)","score":0.4257444441318512},{"id":"https://openalex.org/keywords/biological-system","display_name":"Biological system","score":0.37124550342559814},{"id":"https://openalex.org/keywords/chemistry","display_name":"Chemistry","score":0.365197092294693},{"id":"https://openalex.org/keywords/artificial-intelligence","display_name":"Artificial intelligence","score":0.31851744651794434},{"id":"https://openalex.org/keywords/statistics","display_name":"Statistics","score":0.2968003749847412},{"id":"https://openalex.org/keywords/computer-science","display_name":"Computer science","score":0.23753759264945984},{"id":"https://openalex.org/keywords/stereochemistry","display_name":"Stereochemistry","score":0.2070913016796112},{"id":"https://openalex.org/keywords/biology","display_name":"Biology","score":0.06969577074050903}],"concepts":[{"id":"https://openalex.org/C164126121","wikidata":"https://www.wikidata.org/wiki/Q766383","display_name":"Quantitative structure\u2013activity relationship","level":2,"score":0.8769270181655884},{"id":"https://openalex.org/C139945424","wikidata":"https://www.wikidata.org/wiki/Q1940696","display_name":"Mean squared error","level":2,"score":0.6086426973342896},{"id":"https://openalex.org/C2775905019","wikidata":"https://www.wikidata.org/wiki/Q192572","display_name":"In silico","level":3,"score":0.5244691371917725},{"id":"https://openalex.org/C22354355","wikidata":"https://www.wikidata.org/wiki/Q422009","display_name":"Partial least squares regression","level":2,"score":0.5166683197021484},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.5064398050308228},{"id":"https://openalex.org/C48921125","wikidata":"https://www.wikidata.org/wiki/Q10861030","display_name":"Linear regression","level":2,"score":0.48308637738227844},{"id":"https://openalex.org/C189430467","wikidata":"https://www.wikidata.org/wiki/Q7293293","display_name":"Ranking (information retrieval)","level":2,"score":0.4257444441318512},{"id":"https://openalex.org/C186060115","wikidata":"https://www.wikidata.org/wiki/Q30336093","display_name":"Biological system","level":1,"score":0.37124550342559814},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.365197092294693},{"id":"https://openalex.org/C154945302","wikidata":"https://www.wikidata.org/wiki/Q11660","display_name":"Artificial intelligence","level":1,"score":0.31851744651794434},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.2968003749847412},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.23753759264945984},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.2070913016796112},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.06969577074050903},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000465","descriptor_name":"Algorithms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000465","descriptor_name":"Algorithms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000465","descriptor_name":"Algorithms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001189","descriptor_name":"Aryl Hydrocarbon Hydroxylases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D001189","descriptor_name":"Aryl Hydrocarbon Hydroxylases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D001189","descriptor_name":"Aryl Hydrocarbon Hydroxylases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D003198","descriptor_name":"Computer Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D003198","descriptor_name":"Computer Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D003198","descriptor_name":"Computer Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006899","descriptor_name":"Mixed Function Oxygenases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D006899","descriptor_name":"Mixed Function Oxygenases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D006899","descriptor_name":"Mixed Function Oxygenases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D012044","descriptor_name":"Regression Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012044","descriptor_name":"Regression Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012044","descriptor_name":"Regression Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016018","descriptor_name":"Least-Squares Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016018","descriptor_name":"Least-Squares Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016018","descriptor_name":"Least-Squares Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D021281","descriptor_name":"Quantitative Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D021281","descriptor_name":"Quantitative Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D021281","descriptor_name":"Quantitative Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D051544","descriptor_name":"Cytochrome P-450 CYP3A","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051544","descriptor_name":"Cytochrome P-450 CYP3A","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051544","descriptor_name":"Cytochrome P-450 CYP3A","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065607","descriptor_name":"Cytochrome P-450 Enzyme Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D065607","descriptor_name":"Cytochrome P-450 Enzyme Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D065607","descriptor_name":"Cytochrome P-450 Enzyme Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D065609","descriptor_name":"Cytochrome P-450 CYP1A2 Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065609","descriptor_name":"Cytochrome P-450 CYP1A2 Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065609","descriptor_name":"Cytochrome P-450 CYP1A2 Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065690","descriptor_name":"Cytochrome P-450 CYP2D6 Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065690","descriptor_name":"Cytochrome P-450 CYP2D6 Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065690","descriptor_name":"Cytochrome P-450 CYP2D6 Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065729","descriptor_name":"Cytochrome P-450 CYP2C9","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065729","descriptor_name":"Cytochrome P-450 CYP2C9","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065729","descriptor_name":"Cytochrome P-450 CYP2C9","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065731","descriptor_name":"Cytochrome P-450 CYP2C19","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065731","descriptor_name":"Cytochrome P-450 CYP2C19","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065731","descriptor_name":"Cytochrome P-450 CYP2C19","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1007/s10822-007-9139-6","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s10822-007-9139-6","pdf_url":null,"source":{"id":"https://openalex.org/S64621741","display_name":"Journal of Computer-Aided Molecular Design","issn_l":"0920-654X","issn":["0920-654X","1573-4951"],"is_oa":false,"is_in_doaj":false,"is_core":true,"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Computer-Aided Molecular Design","raw_type":"journal-article"},{"id":"pmid:18034311","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18034311","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of computer-aided molecular design","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":51,"referenced_works":["https://openalex.org/W20683381","https://openalex.org/W107900956","https://openalex.org/W122255638","https://openalex.org/W628735620","https://openalex.org/W1594031697","https://openalex.org/W1889740990","https://openalex.org/W1967635606","https://openalex.org/W1968500384","https://openalex.org/W1975206909","https://openalex.org/W1986838867","https://openalex.org/W1995425465","https://openalex.org/W2003237988","https://openalex.org/W2004495400","https://openalex.org/W2014919794","https://openalex.org/W2017016867","https://openalex.org/W2023162917","https://openalex.org/W2028105139","https://openalex.org/W2029034487","https://openalex.org/W2037441277","https://openalex.org/W2039956662","https://openalex.org/W2044636211","https://openalex.org/W2046666829","https://openalex.org/W2052226480","https://openalex.org/W2055005853","https://openalex.org/W2055703272","https://openalex.org/W2061266768","https://openalex.org/W2074402745","https://openalex.org/W2079790786","https://openalex.org/W2080242559","https://openalex.org/W2087661061","https://openalex.org/W2087952495","https://openalex.org/W2090917557","https://openalex.org/W2099646268","https://openalex.org/W2105587896","https://openalex.org/W2106109834","https://openalex.org/W2114951391","https://openalex.org/W2124888643","https://openalex.org/W2149701488","https://openalex.org/W2150641509","https://openalex.org/W2152381351","https://openalex.org/W2152820192","https://openalex.org/W2155268095","https://openalex.org/W2156423252","https://openalex.org/W2161471267","https://openalex.org/W2166592632","https://openalex.org/W2170930327","https://openalex.org/W2212449076","https://openalex.org/W2288383525","https://openalex.org/W2341952449","https://openalex.org/W2503993098","https://openalex.org/W3085162807"],"related_works":["https://openalex.org/W2382340815","https://openalex.org/W1972650408","https://openalex.org/W2551736466","https://openalex.org/W1997566113","https://openalex.org/W3189652131","https://openalex.org/W2908740012","https://openalex.org/W1967793880","https://openalex.org/W2792066564","https://openalex.org/W1965106906","https://openalex.org/W2575795810"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":8}],"updated_date":"2026-06-11T09:08:48.828518","created_date":"2025-10-10T00:00:00"}